Royal University Hospital, often abbreviated RUH, is one of four hospitals in Saskatoon, Saskatchewan. It is located on the University of Saskatchewan campus. RUH is a teaching hospital and closely tied to the College of Medicine within the university.

During the past decade, Royal University Hospital conducted 90 clinical trials. In the 10-year time frame, 90 clinical trials started and 30 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 21 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal University Hospital" #1 sponsor was "University of Saskatchewan" with 39 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "University of British Columbia" with 5 trials sponsored and "University of Calgary" with 5 trials sponsored. Other sponsors include 99 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal University Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 22 trials as a collaborator, "Royal University Hospital Foundation" with 10 trials as a collaborator, "London Health Sciences Centre" with 5 trials as a collaborator, "The Hospital for Sick Children" with 5 trials as a collaborator and "University of Calgary" with 5 trials as a collaborator. Other collaborators include 164 different institutions and companies that were collaborators in the rest 125 trials.

According to Clinical.Site data, the most researched conditions in "Royal University Hospital" are "Ulcerative Colitis" (14 trials), "Stroke" (7 trials), "Coronary Artery Disease" (6 trials), "Crohn Disease" (5 trials) and "Crohn's Disease" (5 trials). Many other conditions were trialed in "Royal University Hospital" in a lesser frequency.

Most popular intervention types in "Royal University Hospital" are "Drug" (98 trials), "Other" (19 trials), "Device" (18 trials), "Procedure" (12 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Etrolizumab" (4 trials), "Filgotinib" (4 trials), "Acetaminophen" (3 trials) and "Guselkumab Dose 1" (3 trials). Other intervention names were less common.

The vast majority of trials in "Royal University Hospital" are 147 trials for "All" genders, 15 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Royal University Hospital". undefined are not yet recruiting, 21 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 84 completed trials in Royal University Hospital, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Royal University Hospital, 6 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 33 trials that are defined as “Not Applicable".